Predictions
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€1.85
23.01.21
23.01.21
€60.00
23.01.22
23.01.22
-41.51%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Star Equity Holdings Inc.
Start price
Target price
Perf. (%)
€3.16
23.01.21
23.01.21
€30.00
23.01.22
23.01.22
-67.09%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.36
23.01.21
23.01.21
€100.00
23.01.22
23.01.22
-77.10%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Advaxis Inc.
Start price
Target price
Perf. (%)
€0.62
23.01.21
23.01.21
€60.00
23.01.22
23.01.22
-81.94%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Arca Biopharma
Start price
Target price
Perf. (%)
€3.98
23.01.21
23.01.21
€30.00
23.01.22
23.01.22
-60.05%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.19
23.01.21
23.01.21
€20.00
23.01.22
23.01.22
-51.51%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Teligent Inc.
Start price
Target price
Perf. (%)
€0.99
23.01.21
23.01.21
-
23.01.22
23.01.22
-97.97%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€35.75
23.01.21
23.01.21
-
23.01.22
23.01.22
-73.67%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€17.60
10.01.22
10.01.22
-
10.01.23
10.01.23
-27.39%
23.01.22
23.01.22
Risky Investment
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.14
09.01.22
09.01.22
-
09.01.23
09.01.23
-5.80%
23.01.22
23.01.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.00
17.01.22
17.01.22
-
17.01.23
17.01.23
-44.67%
22.01.22
22.01.22
Risky Investment
Crossject S.A.
Start price
Target price
Perf. (%)
€3.67
21.01.21
21.01.21
€10.00
21.01.22
21.01.22
-28.61%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
Dare Bioscience Inc.
Start price
Target price
Perf. (%)
€2.50
21.01.21
21.01.21
€10.00
21.01.22
21.01.22
-47.52%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
Lipocine Inc.
Start price
Target price
Perf. (%)
€32.30
21.01.21
21.01.21
€136.00
21.01.22
21.01.22
-57.58%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
Biocept Inc.
Start price
Target price
Perf. (%)
€147.00
21.01.21
21.01.21
€3,000.0
21.01.22
21.01.22
-48.16%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
NanoVibronix Inc.
Start price
Target price
Perf. (%)
€30.00
04.10.21
04.10.21
-
04.10.22
04.10.22
-39.47%
10.01.22
10.01.22
Could be worthwhile Investment >10% per year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€18.94
05.01.22
05.01.22
-
05.01.23
05.01.23
-7.08%
09.01.22
09.01.22
Risky Investment
NanoVibronix Inc.
Start price
Target price
Perf. (%)
€52.08
13.08.21
13.08.21
€20.00
13.08.22
13.08.22
-65.13%
08.01.22
08.01.22
Probably not worthwhile Investment
Very low/no dividend yield expected
Little Investments for future growth
ROE lower than 10% per year
BiondVax Pharmaceuticals Ltd ADR
Start price
Target price
Perf. (%)
€22.60
28.12.21
28.12.21
-
28.12.22
28.12.22
-32.74%
07.01.22
07.01.22
Probably not worthwhile Investment
Tenax Therapeutics Inc.
Start price
Target price
Perf. (%)
€30.38
30.12.20
30.12.20
-
30.12.21
30.12.21
-41.67%
31.12.21
31.12.21
Probably not worthwhile Investment
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€23.29
13.12.21
13.12.21
€20.00
13.12.22
13.12.22
-12.88%
30.12.21
30.12.21
Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Risky balance sheet
BiondVax Pharmaceuticals Ltd ADR
Start price
Target price
Perf. (%)
€24.60
22.12.21
22.12.21
-
22.12.22
22.12.22
-15.45%
25.12.21
25.12.21
Risky Investment
Pixium Vision S.A.
Start price
Target price
Perf. (%)
€1.03
17.02.21
17.02.21
€3.00
17.02.22
17.02.22
-24.32%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
Euromedis Groupe
Start price
Target price
Perf. (%)
€22.15
12.04.21
12.04.21
€28.35
12.04.22
12.04.22
-51.96%
24.12.21
24.12.21
Could be worthwhile Investment >10% per year
CEL-SCI Corp.
Start price
Target price
Perf. (%)
€9.80
22.10.21
22.10.21
€1.00
22.10.22
22.10.22
-27.76%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year